AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $36,933,000 | +81.1% | 2,441,120 | -10.2% | 0.00% | 0.0% |
| Q2 2022 | $20,397,000 | -12.4% | 2,719,487 | +6.3% | 0.00% | 0.0% |
| Q1 2022 | $23,291,000 | -1.9% | 2,559,480 | -24.3% | 0.00% | 0.0% |
| Q4 2021 | $23,736,000 | -52.4% | 3,381,368 | -22.7% | 0.00% | 0.0% |
| Q3 2021 | $49,895,000 | -28.4% | 4,376,806 | +0.6% | 0.00% | -50.0% |
| Q2 2021 | $69,639,000 | -8.3% | 4,349,682 | +2.3% | 0.00% | 0.0% |
| Q1 2021 | $75,962,000 | +33.3% | 4,250,754 | +0.8% | 0.00% | 0.0% |
| Q4 2020 | $56,973,000 | +19.9% | 4,217,071 | +4.5% | 0.00% | 0.0% |
| Q3 2020 | $47,498,000 | -24.5% | 4,035,457 | -5.3% | 0.00% | 0.0% |
| Q2 2020 | $62,873,000 | +7.2% | 4,259,708 | -1.9% | 0.00% | 0.0% |
| Q1 2020 | $58,629,000 | -42.8% | 4,342,814 | +2.5% | 0.00% | -33.3% |
| Q4 2019 | $102,421,000 | +28.4% | 4,237,491 | +2.1% | 0.00% | 0.0% |
| Q3 2019 | $79,798,000 | -35.5% | 4,151,813 | -0.9% | 0.00% | -40.0% |
| Q2 2019 | $123,769,000 | -36.6% | 4,188,446 | +1.9% | 0.01% | -37.5% |
| Q1 2019 | $195,152,000 | +33.9% | 4,108,461 | +1.8% | 0.01% | +14.3% |
| Q4 2018 | $145,716,000 | -39.1% | 4,036,437 | +3.8% | 0.01% | -22.2% |
| Q3 2018 | $239,281,000 | +2.7% | 3,887,580 | +12.7% | 0.01% | -10.0% |
| Q2 2018 | $233,089,000 | +34.2% | 3,450,616 | +7.7% | 0.01% | +25.0% |
| Q1 2018 | $173,745,000 | -4.9% | 3,202,650 | +4.8% | 0.01% | 0.0% |
| Q4 2017 | $182,605,000 | +25.2% | 3,056,143 | +1.8% | 0.01% | +14.3% |
| Q3 2017 | $145,870,000 | +28.6% | 3,001,439 | +39.0% | 0.01% | +16.7% |
| Q2 2017 | $113,446,000 | +79.6% | 2,158,825 | +55.0% | 0.01% | +100.0% |
| Q1 2017 | $63,151,000 | +28.3% | 1,392,525 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $49,207,000 | +14.7% | 1,300,062 | +14.4% | 0.00% | 0.0% |
| Q3 2016 | $42,897,000 | +142.1% | 1,136,658 | +12.9% | 0.00% | +200.0% |
| Q2 2016 | $17,716,000 | +60.8% | 1,006,552 | +11.1% | 0.00% | 0.0% |
| Q1 2016 | $11,015,000 | -47.0% | 905,907 | +6.1% | 0.00% | 0.0% |
| Q4 2015 | $20,785,000 | -93.2% | 853,556 | -89.8% | 0.00% | -90.9% |
| Q3 2015 | $305,262,000 | +2886.3% | 8,405,103 | +1351.3% | 0.01% | +1000.0% |
| Q2 2015 | $10,222,000 | -39.8% | 579,159 | +6.9% | 0.00% | 0.0% |
| Q1 2015 | $16,985,000 | +77.8% | 541,958 | +65.6% | 0.00% | 0.0% |
| Q4 2014 | $9,551,000 | +74.4% | 327,233 | +23.6% | 0.00% | – |
| Q3 2014 | $5,476,000 | +14.3% | 264,653 | +36.8% | 0.00% | – |
| Q2 2014 | $4,791,000 | +38.3% | 193,405 | +18.3% | 0.00% | – |
| Q1 2014 | $3,465,000 | +109.5% | 163,483 | +77.5% | 0.00% | – |
| Q4 2013 | $1,654,000 | – | 92,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|